AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05365802 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: As part of PET/CT scan
Study NCT05365802 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: High Resolution Computed Tomography
Description: Will be conducted immediately after FAPI PET/CT
Study NCT05588700 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Physical activity recommendations
Description: At the baseline, all participants will receive the international recommendations in terms of physical activity for promoting health in the general population.
Study NCT05588700 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity recommendations
Description: At the baseline, all participants will receive the international recommendations in terms of physical activity for promoting health in the general population.
Study NCT05588700 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Connected activity tracker
Description: At baseline, all participants will receive a connected activity tracker to wear 24 hours a day during one year. Patients will be asked to download an application, dedicated to the study so that the physical activity data (ie. number of steps per day) will be synchronized in the application.
Study NCT05588700 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Connected activity tracker
Description: At baseline, all participants will receive a connected activity tracker to wear 24 hours a day during one year. Patients will be asked to download an application, dedicated to the study so that the physical activity data (ie. number of steps per day) will be synchronized in the application.
Study NCT05588700 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) Intervention
Description: The intervention will last 1 year and will have 2 phases. Phase 1: At each cycle of chemotherapy, patients will be proposed to perform 2-4 sessions per week. This program will be individual, supervised, performed at a moderate intensity. Between cycles, patients will be asked to perform 1-2 supervised collective live online physical activity sessions per week, proposed by a partner specialized in online PA.~Phase 2: After chemotherapy, patients will be asked to perform 2-3 PA sessions per week at a moderate intensity. Patients will be offered 2 options of PA practice: in the supervised collective live online PA session (as already performed in the phase 1), and/or in a fitness center (this practice will take place in a classic environment with a 9-month free access for patients thanks to a partnership).~In addition, patients will benefit from 4 individual motivational interviews, conducted by videoconference and/or by phone call with a professional.
Study NCT04894370 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Sample collection
Description: PBMC collection at baseline, after radiotherapy 8 Gy (gray), at 6 months and at 12 months from inclusion: 6 EDTA tubes of 6 ml of peripheral blood mononuclear cell \[PBMC\] will be sent to the central laboratory (Biomonitoring Platform of Besançon, CHRU de Besançon located at Etablissement Français du Sang) at room temperature within 24 hours via an approved carrier for their processing, storage and immunomonitoring analysis. A sending sheet of the samples will be attached to each single sample.~Plasma collection at baseline, after radiotherapy 8 Gy, at 6 months and at 12 months from inclusion: One 6 ml EDTA tube should be frozen in each investigation center for plasma collection.~Plasma for circulating tumoral DNA (ctDNA) collection at baseline, at 2, 6 and 12 months from inclusion: two EDTA tube of 4 ml should be frozen in each investigation center for ctDNA collection.
Study NCT05369858 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [14C] SKLB1028
Description: A single 150 mg oral dose of \[14C\] SKLB1028 containing approximately 120 microcurie of \[14C\] SKLB1028
Study NCT06105385 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Suboccipital Myofascial Release Technique
Description: With the patient in a supine position, the therapist sits behind the patient with his or her forearms on the treatment table. The therapist places his fingers between the occiput and axis, with his fingers in semi-flexion (2nd, 3rd and 4th fingers), and continues to hold his hands on the occiput until relaxation is achieved in the suboccipital muscles. A light traction is applied at the end of the technique. Average application time is 4-5 minutes.
Study NCT05102188 — intervention group
Intervention type: COMBINATION_PRODUCT
Intervention: Assessment of sleep and related factors
Description: Eligible participants will be invited to fill out several forms and wear a watch-like device on their wrist (an accelerometer) for 7 days to assess their sleep habits. They will also be asked to sleep at home with a watch-like device attached to a sleeve which covers their index finger (an oximeter) for one night to assess whether they may have a sleep problem like sleep apnea.
Study NCT05443802 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Insulin 0.05 IU/kg/h
Description: In the experimental arm, the patients will be given an insulin dose of 0.05 IU/kg/h.
Study NCT05889832 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: measurement of physiological parameters wih Shen.AI Vitals software on various camera-equipped devices (smartphones, tablets, laptops)
Description: Resting heart rate (HR), heart rate variability (HRV) and breathing rate (BR) will be measured (estimated) with the use of remote photoplethysmography (1-minute face video analysis with Shen.AI Vitals software).~Reference measurements will be taken simultaneously (chest ECG for the calculation of HR and HRV; impedance pneumography for BR).
Study NCT06430606 — intervention group
Intervention type: PROCEDURE
Intervention: Tint Time
Description: Arterial blood gas was obtained immediately after intubation(Tint) in supine position. Ventilator parameters and hemodynamic parameters were recorded.
Study NCT05443802 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Insulin 0.10 IU/kg/h
Description: In the control arm, patients will receive an insulin dose of 0.10 IU/kg/h.
Study NCT06430606 — intervention group
Intervention type: PROCEDURE
Intervention: T0 Time
Description: Arterial blood gas was obtained immediately after pneumoperitoneum in trendelenburg position. Ventilator parameters and hemodynamic parameters were recorded.
Study NCT06430606 — intervention group
Intervention type: PROCEDURE
Intervention: T1
Description: Arterial blood gas was obtained immediately after pneumoperitoneum in trendelenburg position. Ventilator parameters and hemodynamic parameters were recorded.
Study NCT04839627 — intervention group
Intervention type: OTHER
Intervention: serum progesterone measurement
Description: progesterone levels measurement on the day of the embryo transfer on all AMP cycles
Study NCT05351970 — intervention group
Intervention type: PROCEDURE
Intervention: Barbed
Description: Efficacy of barbed and monofilament closure regarding incisional hernia
Study NCT05364554 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-77242113
Description: JNJ-77242113 tablet will be administered orally.
Study NCT05499468 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Popular-Opinion Leader-led encouragement during training meetings and informal conversation
Description: Investigators adapted evidence-based principles from the Popular Opinion Leader framework to increase utilizations of existing one-on-one emotional support resources for physicians-in-training at Stanford (an effective HIV prevention intervention developed by the CDC for changing social norms and reducing behavioral risk factors led by influential members of a community, trained to promote behavior change). All intervention activities designed to encourage utilization were delivered as part of health promotion during pre-existing clinical training meetings and no data was collected during these workshops. Identified POLs were recruited and trained to encourage their colleagues to use existing support resources and engage in two 30-60 minute workshops scheduled to occur during training meetings.
Study NCT04619732 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Monitoring biochemical concentrations during cold machine perfusion
Description: Three microdialysis probes will be introduced into the kidney tissues, the vein and ureter in order to measure creatinine, glucose and lactate while the organ is undergoing cold perfusion prior to transplantation.
Study NCT04834635 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: FundoRingOAGB
Description: laparoscopic one anastomosis gastric bypass with the total wrapping of the fundus of gastric excluded part and with suture cruroplasty if present hiatal hernia
Study NCT04834635 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: OAGB
Description: laparoscopic one anastomosis gastric bypass with suture cruroplasty if present hiatal hernia
Study NCT04550741 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: telerehabilitation
Description: After obtaining consent, the volunteers will be included in the study at the start of the 4th week and randomized into two arms: Experimental and Control group
Study NCT06367933 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: mini-invasive spine surgery
Description: spine deformity correction using a mini-invasive technique
Study NCT04569227 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EC-18
Description: 2000 mg PO daily
Study NCT06241183 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intravenous Famotidine
Description: Patients in this group will receive 20mg IV Famotidine.
Study NCT06241183 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oral Maalox/ Mylanta
Description: Patients in this group will receive 30 ml Maalox/ Mylanta.
Study NCT04989023 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Blood flow restriction (BFR) with low load resistance training
Description: Combination of low load resistance exercise in the upper or lower limb with the addition of blood flow restriction or sham-blood flow restriction.
Study NCT04989023 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Blood flow restriction (BFR) with low load resistance training
Description: Combination of low load resistance exercise in the upper or lower limb with the addition of blood flow restriction or sham-blood flow restriction.
Study NCT04569227 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: PO daily
Study NCT06305910 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment with CD200AR-L
Description: Treatment with CD200AR-L (up to 3 dose levels of CD200AR-L with a Dose Level -1 in the event of toxicity) with fixed doses of GBM6-AD vaccine. Each patient will also be given topical imiquimod and a single dose of 300cGy re-irradiation.
Study NCT06483698 — intervention group
Intervention type: OTHER
Intervention: Sublobar resection
Description: Sublobar resection is a series of surgical approaches for lung cancer.
Study NCT06483698 — intervention group
Intervention type: OTHER
Intervention: Lobectomy
Description: Lobectomy is the surgical approach for lung cancer.
Study NCT05034237 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ND;YAG 1064NM LASER
Description: laser hair removal sessions
Study NCT06209268 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paricalcitol injection
Description: 5 μg intravenous paricalcitol (1 mL) per day in five consecutive days
Study NCT06209268 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 0.9% NaCl 1 ml per day in five consecutive days
Study NCT06151821 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Guided meditation
Description: Meditation with guidance
Study NCT06520046 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental Group
Description: Propioceptive exercises
Study NCT06520046 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Group
Description: Usual exercises
Study NCT06443138 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Personalized pre-habilitation program
Description: Each patient will undergo 4 weeks of individualized pre-habilitation before surgery.~Each session (1 session per day) will be carried out autonomously by the patient at home, via a dedicated application (Activiti Pro) installed on their tablet or smartphone.
Study NCT05121129 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: iTBS
Description: 25 active iTBS sessions (5 sessions of 9.5 minutes/day, 1,800 pulses per session, 90% of resting motor threshold, placed over the left DLPFC)
Study NCT04652609 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PRESIONA
Description: Aerobic and strength exercise combined with restricction blood flow cuffs during chemotherapy treatment
Study NCT04797026 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Letters to increase social connection with goal to alleviate loneliness
Description: Our hypothesis is that a social program connecting patients in residential care facilities with high school students through monthly letter writing would positively impact quality of life for both, reducing quantitative and qualitiative measures of loneliness
Study NCT04849871 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: External Beam Accelerated Partial Breast Irradiation
Description: APBI simulation must take place no more than 8 weeks from final definitive breast surgery.
Study NCT05900778 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HABIT-ILE
Description: 2 weeks HABIT-ILE
Study NCT05900778 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Conventional intervention
Description: 2 weeks usual intervention (waitlist group)
Study NCT04581993 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Super Cereal - wheat soya blend with sugar
Description: Pregnant and lactating women will received Super Cereal during pregnancy and first six months of lactation.
Study NCT04581993 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplement-medium quantity (LNS-MQ)
Description: Children will receive LNS during 6-23 months of age.
Study NCT04581993 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social and behavior change communication (SBCC)
Description: SBCC will be provided to improve care-givers knowledge, attitudes and practices related to infant and young child feeding.
Study NCT05377619 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prucalopride
Description: prucalopride 2 mg 1 hour before the challenge with intake of wine (200 ml) and a dinner
Study NCT05377619 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Buspirone
Description: buspirone 10 mg 1 hour before the challenge with intake of wine (200 ml) and a dinner
Study NCT05377619 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo 1 hour before the challenge with intake of wine (200 ml) and a dinner
Study NCT06555484 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Cross Over Assignment Supplemental Oxygen and Supplemental Air
Description: Subjects repeatedly complete memory tests, either first while breathing supplemental oxygen or first while breathing supplemental air (in an order randomly assigned).
Study NCT06268938 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Canal wall down tympanomastoidectomy
Description: Mastoid cavity obliteration by in canal wall down tympanomastoidectomy tympanomastoidectomy in cholesteatoma surgery
Study NCT06268938 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Canal wall down tympanomastoidectomy
Description: Mastoid cavity obliteration by in canal wall down tympanomastoidectomy tympanomastoidectomy in cholesteatoma surgery
Study NCT05034601 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ESPB group
Description: A 21-gauge 100-mm needle will be inserted into the fascial layer beneath the iliocostalis, longissimus, and spinalis muscles. A bolus of 0.25% ropivacaine 0.5 ml/kg will be injected into the fascial layer. Contralateral ESPB will be performed similarly.
Study NCT05034601 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: TPVB group
Description: A 21-gauge 100-mm insulated needle will be inserted into the paravertebral space via an in-plane parasagittal approach. After perforating the costotransverse ligament, 0.25% ropivacaine 0.5 ml/kg will be injected. Anterior movement of the pleura indicated the appropriate spread of the local anesthetics in the paravertebral space. The process will be repeated on the contralateral side.
Study NCT06124391 — intervention group
Intervention type: OTHER
Intervention: Long-term follow-up
Description: Participants diagnosed with PCOS were not subjected to any specific intervention post-diagnosis. Instead, they were followed up after 6.5 years to assess various outcomes related to PCOS and associated conditions.
Study NCT05888753 — intervention group
Intervention type: PROCEDURE
Intervention: Adrenalectomy
Description: Scheduled adrenal surgery
Study NCT05583396 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Acute exercise
Description: The measurement will be repeated within one to seven days.
Study NCT04649775 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: AirFLO2
Description: Mask device
Study NCT06330922 — intervention group
Intervention type: OTHER
Intervention: Cardiorespiratory fitness training
Description: Cardiorespiratory fitness training will be performed two times a week for one hour in small groups (4-5 people). The training will be conducted outdoors at track and field facilities with at least two coaches.
Study NCT05464004 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nintendo Wii balance board
Description: Experimental group was given Nintendo Wii balance board therapy in combination with conventional physical therapy for 16 sessions/8 weeks~Control group was conventional physical therapy which include stretching of the hamstrings, quadriceps and calf muscles. strengthening of the lower limb. Balance exercises include walk in parallel bar
Study NCT05464004 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Nintendo Wii balance board
Description: Experimental group was given Nintendo Wii balance board therapy in combination with conventional physical therapy for 16 sessions/8 weeks~Control group was conventional physical therapy which include stretching of the hamstrings, quadriceps and calf muscles. strengthening of the lower limb. Balance exercises include walk in parallel bar
Study NCT05312671 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab
Description: Atezolizumab 20 mL (1200 mg) on Day 1, once every 3 weeks for up to 20 cycles (each cycle = 21 days)
Study NCT05312671 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Carboplatin AUC 5 IV on Day 1, once every 3 weeks for first 4 cycles (each cycle = 21 days).
Study NCT05312671 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Cisplatin 70 mg/m2 IV on Day 1, once every 3 weeks for first 4 cycles (each cycle = 21 days).
Study NCT05312671 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: Etoposide 100 mg/m2 IV on Days 1 - 3 every cycle for the first 4 cycles (each cycle = 21 days)
Study NCT05312671 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cystectomy
Description: Cystectomy should be performed within 42 days after completion of last administered study therapy of induction phase (first 4 cycles of chemotherapy).
Study NCT05374265 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Cardiovascular Magnetic Resonance Scan
Description: Patients will receive a baseline CMR scan to detect viability within 7 days of index admission
Study NCT05625035 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lianhua Qingwen capsules
Description: Lianhua Qingwen capsules: 4 capsules once, three times daily
Study NCT05640570 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: The individualized Jade Wind-Barrier Herbal Tea Bag
Description: The individualized Jade Wind Barrier Herbal Tea Bag is composed of Astragali Radix (Zhi Huangqi) 4g, Saposhnikoviae Radix (Fangfeng) 2g, Atractylodes macrocephala Koidz (Baizhu) 2g, Nelumbinis Folium (Heye) 1g, Chrysanthemum morifolium Ramat (Juhua) 1g.
Study NCT04865432 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: UVB treatment
Description: 5 weeks of UVB titration to determine individual's UVB sensitivity followed by 4 weeks of UVB exposure intervention
Study NCT04820790 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mobile applications
Description: Monitoring of patients with home oxygen through a mobile application
Study NCT05685290 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pushing with saline technique
Description: Peripheral venous catheter placement by pushing with saline technique
Study NCT05685290 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Traditional method
Description: Peripheral venous catheter placement with the traditional method by nurses in the clinic routinely.
Study NCT06198816 — intervention group
Intervention type: OTHER
Intervention: ultrasound accelerated thrombolysis and venoplasty
Description: IDOLO Study investigate clinical efficacy on ultrasound accelerated thrombolysis and venoplasty in patients with post-thrombotic syndrome secondary to chronical femoro-popliteal vein occlusion for previous deep vein Thrombosis (DVT).